--- title: "Insilico Medicine climbs 6%" type: "News" locale: "en" url: "https://longbridge.com/en/news/304786592.md" description: "Insilico Medicine rose 6.09% to HK$39.74. Down 38.32% over six months and up 6.79% YTD." datetime: "2026-11-09T02:05:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/304786592.md) - [en](https://longbridge.com/en/news/304786592.md) - [zh-HK](https://longbridge.com/zh-HK/news/304786592.md) generator: "portal-rs" --- # Insilico Medicine climbs 6% Insilico Medicine (3696.HK) climbed more than **6%** in Hong Kong trading to **HK$39.74**. The stock is up 8.66% over the past ten sessions, down 38.32% over the past six months and up 6.79% year to date. It sits 32.56% above its 52-week low of HK$29.98. The Hang Seng Index is up 5.39% over the past five sessions and down 3.81% year to date. The life sciences tools and services industry index rose 3.7% over the same period. The company plans to invest about 303 million yuan to co-establish a biopharmaceutical investment fund with a target size of 1.01 billion yuan, focusing on growth-stage companies in biomedicine, life sciences and artificial intelligence. Separately, Insilico announced a share buyback program of up to HK$500 million in the open market, noting that it believes the current share price undervalues its intrinsic value. Phase I clinical data for its AI-designed drug ISM6331, presented at the ESMO congress, showed an objective response rate of 40% in the 130mg mesothelioma cohort. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [03696.HK](https://longbridge.com/en/quote/03696.HK.md) ## Related News & Research - [One AI Stock to Buy for Life After Nvidia](https://longbridge.com/en/news/306399180.md) - [Insilico Medicine Subsidiary Partners With Luoxin Pharmaceuticals on AI-Powered Drug Discovery](https://longbridge.com/en/news/305433887.md) - [INSILICO Plans Share Buyback of Up to HKD500M](https://longbridge.com/en/news/303654455.md) - [Chainfir Capital says AI drug deal headlines mask reliance on uncertain milestone payments](https://longbridge.com/en/news/302495363.md) - [InSilico Medicine Hits Early AI Drug Discovery Milestone in Servier Collaboration](https://longbridge.com/en/news/302341377.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**